Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill to require coverage of continuous glucose monitors for glycogen storage disease
Summary
The Assembly Financial Institutions and Insurance Committee amended and released AB3242, which would require health plans to cover continuous glucose monitoring (CGM) systems for glycogen storage disease and sets an effective date of Jan. 1, 2027. Insurers raised implementation and fiscal concerns during testimony.
The Financial Institutions and Insurance Committee on Feb. 20 amended and released Assembly Bill 3242, which would require coverage of continuous glucose monitoring systems for treatment of glycogen storage disease and set an effective date for individual health policies of Jan. 1, 2027.
Supporters and family members described CGM devices as lifesaving. One speaker said the Dexcom alerts helped prevent dangerous drops in a child’s blood sugar and urged the committee to make the devices…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
